Loading...
A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy – results from a Swedish cohort study
BACKGROUND: To prevent debilitating and irreversible joint damage, rheumatoid arthritis (RA) is often treated with tumor necrosis factor inhibitor (TNFi), but many patients do not respond to this costly therapy. Few predictors for response are known, and it has been proposed that genetic factors whi...
Saved in:
| Published in: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135751/ https://ncbi.nlm.nih.gov/pubmed/27912794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1174-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|